Abstract
Neuroendocrine ductal carcinoma in situ (NE-DCIS) is a breast malignancy that has characteristic clinicopathological features and can, therefore, be regarded as a distinct variant of DCIS. The patient was a 54-year-old premenopausal woman with hemorrhagic nipple discharge in her left breast. Magnetic resonance imaging and ultrasound (US) images of the left breast showed mass-like lesions, while concurrent images of the right breast showed non-mass-like lesions. These findings suggested the presence of both benign and malignant tumors. Pathological findings from US-guided core-needle biopsy of the left mass were highly suspicious of a malignant tumor. Excisional biopsy of both breasts was performed. We could define the diagnosis of breast cancer by the second opinion on pathological diagnosis. The tumor cells showed histological characteristics of NE-DCIS. Bilateral breast lesions had histopathological similarities and were composed of predominantly solid growth of carcinoma cells, frequently with well-developed vascular structures, in mammary ducts and ductules. Carcinoma cells were polygonal or occasionally spindle shaped and had fine-granular, relatively eosinophilic cytoplasm. The nuclei of these cells showed round to ovoid in shape and fine-granular chromatin pattern. There was not any invasive component, as confirmed by careful histological examination. Thus, additional immunohistochemical stainings for NE markers (chromogranin A and synaptophysin) were performed. Staining statuses of these markers were positive in almost all tumor cells from both breasts. Both tumors were therefore diagnosed as NE-DCIS. To our knowledge, this case is the first report of NE-DCIS diagnosed synchronously in both breasts.
Similar content being viewed by others
Abbreviations
- NE-DCIS:
-
Neuroendocrine ductal carcinoma in situ
- E-DCIS:
-
Endocrine ductal carcinoma in situ
- DCIS:
-
Ductal carcinoma in situ
- MRI:
-
Magnetic resonance imaging
- US:
-
Ultrasound
- HER2:
-
Human epidermal growth factor receptor-2
- WHO:
-
World Health Organization
- ER:
-
Estrogen receptor
- PgR:
-
Progesterone receptor
References
Kawasaki T, Nakamura S, Sakamoto G, Murata S, Tsunoda-shimizu H, Suzuki K, et al. Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breast—comparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases. Histopathology. 2008;53:288–98.
Ellis IO, Schnitt SJ, Sastre-Garau X, Bussolati G, Tavassoli FA, Eusebi V, et al. Invasive breast carcinoma. In: Tavassoli FA, Devilee P, editors. Pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press; 2003. p. 13–59.
Tse GM, Ma TK, Chu WC, Lam WW, Poon CS, Chan WC. Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters. Mod Pathol. 2004;17:568–72.
Wilson BS, Lloyd RV. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am J Pathol. 1984;115:458–68.
Wiedenmann B, Franke WW, Kuhn C, Moll R, Gould VE. Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci USA. 1986;83:3500–4.
Cross AS, Azzopardi JG, Krausz T, van Noorden S, Polak JM. A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast. Histopathology. 1985;9:21–37.
Maluf HM, Koerner FC. Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol. 1995;19:1237–44.
Tsang WY, Chan JK. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol. 1996;20:921–43.
Tavassoli FA, Hoefler H, Rosai J, Holland R, Ellis IO. Pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press; 2003. p. 63–73.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Honami, H., Sotome, K., Sakamoto, G. et al. Synchronous bilateral neuroendocrine ductal carcinoma in situ. Breast Cancer 21, 508–513 (2014). https://doi.org/10.1007/s12282-011-0278-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-011-0278-1